Veterinary Artificial Insemination Market Report 2026

The veterinary artificial insemination market size has grown strongly in recent years. It will grow from $4.56 billion in 2025 to $4.9 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to use of natural breeding methods, growing livestock population, increasing demand for high-quality animal progeny, development of basic semen preservation techniques, early adoption of veterinary ai in cattle.

The veterinary artificial insemination market size is expected to see strong growth in the next few years. It will grow to $6.59 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to advancements in sexed semen technology, rising investments in precision breeding, increasing adoption of intracervical and intrauterine insemination techniques, expansion of veterinary ai services in emerging markets, growing focus on wildlife and companion animal breeding programs. Major trends in the forecast period include rising adoption of sexed semen technology, increasing focus on genetic improvement in livestock, expansion of veterinary ai services, growing use of frozen semen for long-distance breeding, enhanced training and awareness programs for farmers.

The rising demand for livestock is expected to drive growth in the veterinary artificial insemination (AI) market in the coming years. Livestock refers to domesticated animals raised in agricultural settings to produce commodities such as meat, milk, eggs, wool, and leather. Increasing demand for animal-based food products is fueling higher farming and breeding activity to meet nutritional and market needs. Veterinary artificial insemination is a widely used technique in livestock production that introduces semen into the female reproductive tract without natural mating, improving livestock quality and productivity. For example, in July 2023, according to the Food and Agriculture Organization, a US-based specialized agency, global milk production in 2023 was projected to reach 944 million tonnes, up 0.9% from 2022, reflecting rising demand for animal-source foods as incomes increase and diets shift toward protein. Therefore, the growing demand for livestock is driving the veterinary artificial insemination market.

Leading players and government initiatives in the veterinary artificial insemination market are focusing on developing innovative solutions, such as comprehensive livestock care services, to provide reliable support to customers. Livestock care services include a wide range of professional practices aimed at promoting animal health, well-being, and productivity. These services are critical for sustainable and profitable livestock production, ensuring the safety of animal products and safeguarding public health. For instance, in April 2023, the Government of Himachal Pradesh, an India-based authority, launched Project Sanjeevani to provide doorstep veterinary services, particularly in remote areas. The project addresses challenges faced by livestock owners in accessing timely and quality veterinary care. By leveraging teleconsultation and mobile applications, veterinary professionals can connect with farmers in remote regions, provide real-time advice, and facilitate timely interventions. The services cover curative treatment, vaccination, artificial insemination, preventive care, and all animal husbandry-related information.

In January 2025, IMV Technologies, a France-based healthcare technology company, acquired Conception Ro Main Inc. for an undisclosed amount. Through this acquisition, IMV Technologies aimed to enhance its portfolio in veterinary reproductive technologies and expand its presence in the livestock artificial insemination market with advanced automation and AI-driven solutions. Conception Ro Main Inc. is a Canada-based technology company providing solutions that support veterinary artificial insemination, specifically within the swine industry.

Major companies operating in the veterinary artificial insemination market are Swine Genetics International, Semex, Gènes Diffusion, CRV Holding B.V., Select Sires Inc., Shipley Swine Genetics, STgenetics, Hamilton Thorne Inc., Microptic, Medical Electronic Systems LLC., Magapor S.L., Proiser, Zoetis India Limited, GenePro Inc., IMV Technologies, Neogen Corporation, Bovine Elite LLC., Agtech Inc., Genex Cooperative Inc., Alta Genetics Inc., ABS Global Inc., Cogent Breeding Ltd., Viking Genetics, Inseme S.r.l., Semen Cardona S.L., Genus PLC, Trans Ova Genetics, Cattle Genetics Ltd., Cattle Breeding Services.

North America was the largest region in the veterinary artificial insemination market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary artificial insemination market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary artificial insemination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the veterinary artificial insemination market by increasing costs of imported semen, reproductive equipment, and specialized AI instruments. This impact is most pronounced in regions like north america and europe, where imports dominate the supply chain for sexed and frozen semen. Segments such as sexed semen and advanced AI instruments are particularly affected, while positive effects include stimulating local production, encouraging domestic innovation, and reducing dependency on global imports.

The veterinary artificial insemination market research report is one of a series of new reports that provides veterinary artificial insemination market statistics, including veterinary artificial insemination industry global market size, regional shares, competitors with a veterinary artificial insemination market share, detailed veterinary artificial insemination market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary artificial insemination industry. This veterinary artificial insemination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary artificial insemination (AI) involves the manual introduction of fresh male animal sperm or a thawed frozen sperm suspension into the female animal's reproductive organs. This procedure addresses logistical challenges associated with natural copulation. It finds application in selective breeding, genetic enhancement, resolving infertility issues, and conservation across various animal species, including cattle, companion animals, and wildlife.

The primary products within veterinary artificial insemination include normal semen and sexed semen. Normal semen is utilized for artificial insemination to improve the genetics and reproduction of farm animals. On average, a typical ejaculation yields 1.5 to 5 milliliters of semen, containing sperm ranging from 15 million to over 200 million per milliliter. This technique is applied in cattle, swine, ovine and caprine, equine, and other species, employing methods such as intracervical insemination, intrauterine insemination, intrauterine tub peritoneal insemination, and intratubal insemination. Veterinary hospitals, veterinary clinics, and related facilities typically carry out these procedures.

The veterinary artificial insemination market consists of revenues earned by entities by providing veterinary artificial insemination services such breeding, scientific doorstep AI facilities, crossbreeding, selective breeding, pure breeding. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary artificial insemination market also includes sales of AI kit, AI gun, AI sheaths, clinical thermometer which are used in providing veterinary artificial insemination services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.